Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

MediWound (MDWD) Income from Continuing Operations (2016 - 2025)

Historic Income from Continuing Operations for MediWound (MDWD) over the last 13 years, with Q3 2025 value amounting to -$6.5 million.

  • MediWound's Income from Continuing Operations fell 2790.51% to -$6.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.0 million, marking a year-over-year decrease of 8705.22%. This contributed to the annual value of -$30.1 million for FY2024, which is 37434.6% down from last year.
  • MediWound's Income from Continuing Operations amounted to -$6.5 million in Q3 2025, which was down 2790.51% from -$13.2 million recorded in Q2 2025.
  • MediWound's Income from Continuing Operations' 5-year high stood at $940000.0 during Q2 2023, with a 5-year trough of -$13.2 million in Q2 2025.
  • Moreover, its 5-year median value for Income from Continuing Operations was -$4.2 million (2021), whereas its average is -$4.5 million.
  • In the last 5 years, MediWound's Income from Continuing Operations skyrocketed by 12162.91% in 2023 and then crashed by 77117.02% in 2024.
  • MediWound's Income from Continuing Operations (Quarter) stood at -$4.2 million in 2021, then crashed by 76.47% to -$7.3 million in 2022, then soared by 79.49% to -$1.5 million in 2023, then crashed by 304.72% to -$6.1 million in 2024, then dropped by 6.39% to -$6.5 million in 2025.
  • Its Income from Continuing Operations stands at -$6.5 million for Q3 2025, versus -$13.2 million for Q2 2025 and -$5.2 million for Q1 2025.